Therapy-Related Myelodysplastic Syndrome Recruiting Phase 1 / 2 Trials for Aldesleukin (DB00041)

IndicationStatusPhase
DBCOND0079186 (Therapy-Related Myelodysplastic Syndrome)Recruiting1 / 2
clinicaltrials.gov IdentifierTitlePurposeDrugs